Given the central role of DCs in all immune responses, and their proposed role in RA and other autoimmune inflammatory diseases, we examined CD1c+ DC, CD141+ DC, and pDCs in patients in the early stages of RA, before treatment with antirheumatic drugs. The gene discussed is CD1C; the disease is rheumatoid arthritis.